Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 13 - Number 1
Mechanistic Insights into the Antileukemic Activity of Hyperforin
, 13(1): 1 - 10C. Billard, F. Merhi and B. Bauvois
DOI: 10.2174/1568009611309010001
Safety and Proof-of-Concept Efficacy of Inhaled Drug Loaded Nano- and Immunonanoparticles in a c-Raf Transgenic Lung Cancer Model
, 13(1): 11 - 29Nour Karra, Taher Nassar, Florian Laenger, Simon Benita and Juergen Borlak
DOI: 10.2174/1568009611309010011
Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?
, 13(1): 30 - 47Hakon Reikvam, Astrid Olsnes Kittang, Guro Melve, Knut Anders Mosevoll, Pal Tore Bentsen, Elisabeth Ersvaer, Bjorn Tore Gjertsen and Oystein Bruserud
DOI: 10.2174/1568009611309010030
Inhibition of Cdc42-Interacting Protein 4 (CIP4) Impairs Osteosarcoma Tumor Progression
, 13(1): 48 - 56Nadezhda V. Koshkina, Ge Yang and Eugenie S. Kleinerman
DOI: 10.2174/1568009611309010048
Inhibition of STAT Signalling in Bladder Cancer by Diindolylmethane - Relevance to Cell Adhesion, Migration and Proliferation
, 13(1): 57 - 68Yiyang Sun, Mai-Kim Cheng, Thomas. R.L.Griffiths, J. Kilian Mellon, Bao Kai, Marina Kriajevska and Margaret M. Manson
DOI: 10.2174/1568009611309010057
Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia
, 13(1): 69 - 79J. Kuroda, Y. Shimura, M. Yamamoto-Sugitani, N. Sasaki and M. Taniwaki
DOI: 10.2174/1568009611309010069
Apoptosis Suppression by Candidate Oncogene PLAC8 is Reversed in Other Cell Types
, 13(1): 80 - 91Mirna Mourtada-Maarabouni, David Watson, Mamoona Munir, Farzin Farzaneh and Gwyn T. Williams
DOI: 10.2174/1568009611309010080
Experimental Therapy for Lung Cancer: Umbilical Cord-Derived Mesenchymal Stem Cell-Mediated Interleukin-24 Delivery
, 13(1): 92 - 102Xu Zhang, Leilei Zhang, Wenrong Xu, Hui Qian, Shengqin Ye, Wei Zhu, Hongcui Cao, Yongmin Yan, Wei Li, Mei Wang, Wei Wang and Ruiwen Zhang
DOI: 10.2174/1568009611309010092
TRPC Channels and Their Splice Variants are Essential for Promoting Human Ovarian Cancer Cell Proliferation and Tumorigenesis
, 13(1): 103 - 116Bo Zeng, Cunzhong Yuan, Xingsheng Yang, Stephen L. Atkin and Shang-Zhong Xu
DOI: 10.2174/1568009611309010103
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net